EICHORCondition: Dyspepsia · Sponsor: Pusan National University Yangsan Hospital
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Galeo® on dyspepsia symptoms in patients with postprandial distress syndrome subtype in functional dyspepsia for 8 weeks.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pusan National University Yangsan Hospital | Yangsan, Gyeungsangnam-do, South Korea | — |
| Hallym University Sacred Heart Hospital | Anyang, South Korea | — |
| Dong-A University Hospital | Busan, South Korea | — |
| Chungnam National University Hospital | Daejeon, South Korea | — |
| Korea University Guro Hospital | Seoul, South Korea | — |
| Koreal University Anam Hospital | Seoul, South Korea | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05199441